IVI hosts webinars to communicate research findings, explore new methodologies in value assessment, and host public dialogue on relevant issues. Join IVI for open conversations about best practices with researchers, patient organizations, policymakers, and those who pay for care.

Below are upcoming and recent IVI webinars. To view all of our past events, visit our webinar archive here.

Recent Events

Real Experience, Real Impact: Valuing Rare Disease Treatments in Healthcare

Date: Wednesday, November 29, 2023
Time: 12:00 PM – 1:00 PM ET

Join the Innovation and Value Initiative (IVI) and EveryLife Foundation for Rare Diseases to explore the critical role of patient-centered outcomes and health technology assessment (HTA) in advancing rare disease therapy development and access. Our panel of experts and key stakeholders will share groundbreaking insights and recommendations from research that places patients at the center of the discussion. (Learn More About IVI’s Rare Disease Initiative)

Real Experience

  • Hear firsthand accounts from patients as they discuss the importance of considering patient-centered outcomes in evaluating rare disease therapies.
  • Discover the outcomes identified through this project that illuminate critical factors that truly matter to patients, caregivers, and families affected by rare diseases.

Real Impact

  • Understand the significance of fostering patient-payer dialogues and multi-stakeholder collaborations in driving meaningful change in HTA for rare disease therapy.
  • Gain perspective on these recommendations to prioritize for implementation of HTA and how these actions are poised to shape the future of HTA for rare disease therapies.

This webinar is designed for a diverse audience, including patients, caregivers, payers, employers, policymakers, pharmaceutical professionals, and researchers.

* This event is organized by the Innovation and Value Initiative, sponsored by Alexion, and partnered with EveryLife Foundation for Rare Diseases.

Richard Chapman
Richard ChapmanChief Science Officer at Innovation and Value Initiative
Annie Kennedy
Annie KennedyChief of Policy, Advocacy & Patient Engagement at EveryLife Foundation for Rare Diseases

View Webinar Recording


IVI-MDD Value Model: Evaluating Treatments for People with Major Depressive Disorder

Date: Thursday, November 9, 2023
Time: 1:00 PM – 2:30 PM ET

The IVI-MDD Value Model is an open-source simulation model that people with MDD, researchers, payers, and employers can use both to understand the economic impacts of MDD and to test new methods in health technology assessment (HTA).

1:00 PM – 2:00 PM
Learn about the background and purpose of the model, areas for which IVI is seeking input, and a demonstration.

2:00 PM – 2:30 PM
We will focus on technical aspects of the model, including challenges, rationale for the model structure, and a preview of planned research projects.

View Webinar Recording


Next Steps Toward Patient Focus in Value Assessment and Payer Decision-Making

Date: Thursday, March 24, 2022
Time: 11:30 AM – 12:45 PM EDT

Decision makers – specifically payers and purchasers – are increasingly aware of the importance of account for patient and family experience and preferences, but the methods for doing so remain unclear. IVI and NEHI recently convened two stakeholder forums* to consider the complex issues of defining, sharing, and integrating patient data and insights into the decision-making process. This webinar will highlight key learnings and identify guideposts for action that evolved from both initiatives.

Attendees will learn about progress in patient-centered value assessment and its impact on payer decision-making.

* Both convenings were partially funded through a Patient-Centered Outcomes Research Institute® (PCORI®) Eugene Washington PCORI® Engagement Award (#EAIN-21156 and #EAIN-1998).

View Recorded Webinar

Andrew Hu, MPP (Moderator)
Andrew Hu, MPP (Moderator)Bipartisan Policy Center
Jennifer Bright, MPA
Jennifer Bright, MPAInnovation and Value Initiative
Tom Hubbard, MPP
Tom Hubbard, MPPNetwork for Excellence in Health Innovation
Andrew Crighton, MD
Andrew Crighton, MDCrighton Consulting Group
Jennifer Graff, PharmD
Jennifer Graff, PharmDAcademy of Managed Care Pharmacy
Maggie Jalowsky
Maggie JalowskySick Cells

AJMC Matters in Managed Care Webinar: Developing Strategies to Drive Value in Mental Health Care

Date: Monday, January 24, 2022
Time: 12:00 PM – 1:00 PM EST

In this webinar, participants heard from top experts who discussed the current state of mental health care, including the growing consensus on the need for change, strategies to provide high value care, and opportunities for collaboration among payers and other healthcare stakeholders. See below for clips from the webinar.

Learning Objectives

  • Highlight common challenges for employers and payers regarding coverage for mental health care
  • Discuss common definitions of value for payers, employers, and people with lived experience
  • Share strategies to incentivize high-value interventions for mental health care
  • Identify opportunities for future collaboration

Speakers included leaders such as, Schroder Stribling (Mental Health America), Michael Thompson (National Alliance of Healthcare Purchaser Coalitions), Jennifer Bright (Innovation and Value Initiative), and Kevin Ronneberg (HealthPartners).

Jennifer Bright, MPA
Jennifer Bright, MPAIVI Executive Director

Part 1


Part 2


Part 3


Part 4


Major Depressive Disorder Model Draft Protocol: Public Comment Period Presentation

Date: Wednesday, December 15, 2021
Time: 1:00 PM – 2:00 PM EST

As part of its Open-Source Value Project, IVI will wold a public comment period on the draft model protocol on major depressive disorder (MDD) from December 14, 2021 – January 18, 2022. The model protocol is a technical document that outlines the primary inputs we plan to use in the MDD economic model.

Join us on Wednesday, December 15th when we outline the major components of the model protocol and answer initial questions.

View Recorded Webinar

Rick Chapman, PhD
Rick Chapman, PhDInnovation and Value Initiative
Chief Science Officer for IVI. Prior to IVI, he was Director of Health Economics at ICER, where he led development of economic evaluations that accompanied reviews of clinical evidence, assessing the potential costs, cost-effectiveness, and budgetary impact of a wide range of pharmaceutical and other clinical interventions.
Jordana Schmier
Jordana SchmierOPEN Health
Ms. Schmier has been working in the health economics and outcomes field for 25 years. Her analyses of patient-reported outcomes and costs of pharmaceuticals, devices, and other health interventions have been widely published and used to support access, regulatory, and reimbursement decisions.
Richard Xie, PhD
Richard Xie, PhDInnovation and Value Initiative
A health economist and HEOR Manager at the Innovation and Value Initiative, Dr. Xie has played a lead role in developing the IVI-Major Depressive Disorder Model Scope. He has a long track record of conducting HEOR studies to inform health policy design and valuation of pharmaceutical therapies.

There is widespread acknowledgement that the data inputs supporting value and health technology assessment are insufficient, both in their lack of representative diversity and their failure to capture real-world factors that matter to communities living with chronic health conditions.

IVI hosted a three-part webinar series to frame discussions about improving equity in research: representing patient community perspectives in the methods that support value assessment and developing policy solutions to support such initiatives. This series was built toward IVI’s second annual Methods Summit in late 2021, where both gaps and emerging approaches in improving patient-centered data inputs to research and value assessment will be examined. The three webinars focused on identifying areas of consensus and current initiatives, as well as essential actions to propel lasting, durable change.

Session 1

Meaningful Action Toward Health Equity

Thursday, April 22, 2021

1:00 PM – 2:15 PM EDT


Session 2

Methods in Value Assessment that Support Equity

Thursday, June 24, 2021

2:00 PM – 3:15 PM EDT


Session 3

Walking the Talk – How Should Policy Uphold Equity in Value Assessment?


1:00 PM – 2:15 PM EDT


After participating in this series, participants were able to:

  • Define and discuss equity issues in the context of value assessment.

  • Consider challenges and solutions in improving representativeness in research.

  • Evaluate existing and emerging methods that support equity in value assessment.

  • Identify policy solutions at all levels that can support improvement in research equity.


  • Health economics and outcomes researchers

  • Patient, family, and disease community researchers and advocates
  • Innovators from pharmaceutical, device, digital, and other healthcare industries

  • Employers

  • Insurers, pharmacy benefit managers, benefits consultants, pathway developers

  • Policymakers

Past Events

IVI Model Scope on Major Depressive Disorder

Date: Monday, May 3, 2021
Time: 1:00 PM EDT

IVI launched the Major Depressive Disorder (MDD) initiative to build a flexible, open-source, and patient-centric model that will help inform the decision needs of multiple stakeholders in the health care system.

According to the National Alliance on Mental Illness, over 19 million adults had at least one MDD episode in the past year; the COVID-19 pandemic has only exacerbated the unmet need for depression treatment. Conventional cost-effectiveness models for assessing the value of MDD treatments typically do not prioritize factors and outcomes important to patients.

This webinar covered the major points of the new model scope for the MDD initiative, and addressed the importance of a patient-centric model for MDD. Via a public comment period from April 12th to May 14th, stakeholders were invited to provide recommendations on the most important factors to build into the model.

Rick Chapman, PhD (Moderator)
Rick Chapman, PhD (Moderator)Innovation and Value Initiative
Jessica Kennedy
Jessica KennedyMental Health America
In her role as Chief of Staff at Mental Health America, Ms. Kennedy focuses on screening, workplace mental health, public education, digital marketing, mental health policy, and program management. She launched the organization’s online screening program in 2014, now the largest database of mental health screens worldwide.
Mohannad (Ned) Kusti, MD, MPH
Mohannad (Ned) Kusti, MD, MPHPivot Onsite-Innovations
A global physician executive and healthcare consultant, Dr. Kusti has unique expertise and experience related to corporate healthcare benefits. He is consulting for numerous employers in COVID-19 corporate management. Dr. Kusti is the Corporate Medical Director at Pivot Onsite-Innovations and also teaches occupational and environmental health sciences at West Virginia University.
Richard Xie, PhD
Richard Xie, PhDInnovation and Value Initiative
A health economist and HEOR Manager at the Innovation and Value Initiative, Dr. Xie has played a lead role in developing the IVI-Major Depressive Disorder Model Scope. He has a long track record of conducting HEOR studies to inform health policy design and valuation of pharmaceutical therapies.

View Recorded Webinar


View Presentation Slides


Principles for Good Value Assessment

Date: Thursday, February 25, 2021
Time: 2:00 PM EST

In December, IVI dubbed 2021 “the year of the patient”: advancing the conversation and practice of patient-centered value assessment in tangible ways. The patient voice is crucial in achieving the promise of value assessment to improve care, achieve better outcomes, and lower costs.

In this webinar, dialogue with IVI and patient advocates about patient-centricity in action and learn more about activities for the year ahead. IVI’s new Principles for Value Assessment in the U.S. was discussed, along with their practical application for patients, employers, and researchers.

Alan Balch, PhD
Alan Balch, PhDPatient Advocate Foundation
Dr. Balch is the Chief Executive Officer of the Patient Advocate Foundation (PAF) and the National Patient Advocate Foundation (NPAF). Dr. Balch is a member of IVI’s Patient Advisory Council.
Jennifer Bright, MPA
Jennifer Bright, MPAInnovation and Value Initiative
Ms. Bright is the Executive Director of the Innovation and Value Initiative. She brings over two decades of healthcare policy, issue management, patient advocacy and executive leadership to this position.

View Recorded Webinar


ISPOR-IVI Webinar Series

IVI and ISPOR collaborated, with the help from an expert advisory committee, to define and host a series of webinars highlighting key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series explored multiple viewpoints and focused on potential pathways for solutions in international and U.S.-focused value assessment and health technology assessment (VA/HTA).

To view all five sessions, visit our webinar archive here.